NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Phase 1/2 Completed
215 enrolled 30 charts
GEMMK
Phase 1/2 Completed
25 enrolled 15 charts
Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer
Phase 1/2 Completed
37 enrolled 13 charts
MK-4280-003
Phase 1/2 Completed
137 enrolled
CICILIA
Phase 1/2 Completed
60 enrolled 18 charts
Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017
Phase 1/2 Completed
35 enrolled 16 charts
JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
Phase 1/2 Completed
21 enrolled
EVICTION-2
Phase 1/2 Completed
56 enrolled
Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer
Phase 1/2 Completed
185 enrolled 23 charts
KEYNOTE145
Phase 1/2 Completed
161 enrolled 29 charts
A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors
Phase 1/2 Completed
161 enrolled 44 charts
Catalyst
Phase 1/2 Completed
6 enrolled 11 charts
Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts
Phase 1/2 Completed
16 enrolled 14 charts
Study of DF9001 in Patients With Advanced Solid Tumors
Phase 1/2 Completed
24 enrolled
KEYMAKER-U02
Phase 1/2 Completed
56 enrolled
A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors
Phase 1/2 Completed
89 enrolled 24 charts
A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
Phase 1/2 Completed
98 enrolled
KEYMAKER-U02
Phase 1/2 Completed
100 enrolled
Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma
Phase 1/2 Completed
50 enrolled 10 charts
The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer
Phase 1/2 Completed
65 enrolled 16 charts
A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations
Phase 1/2 Completed
53 enrolled
Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer
Phase 1/2 Completed
23 enrolled 14 charts
Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery
Phase 1/2 Completed
31 enrolled 20 charts
LUPER
Phase 1/2 Completed
28 enrolled
MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas
Phase 1/2 Completed
55 enrolled 14 charts
Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer
Phase 1/2 Completed
24 enrolled 13 charts
Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma
Phase 1/2 Completed
11 enrolled 12 charts
IMA950-106
Phase 1/2 Completed
18 enrolled
Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies
Phase 1/2 Completed
40 enrolled 11 charts
CMP-001 for Relapsed and Refractory Lymphoma
Phase 1/2 Completed
14 enrolled
JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors
Phase 1/2 Completed
58 enrolled
Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC)
Phase 1/2 Completed
191 enrolled 26 charts
SPRINT
Phase 1/2 Completed
126 enrolled
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
Phase 1/2 Completed
83 enrolled 14 charts
Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer
Phase 1/2 Completed
95 enrolled 26 charts
Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma
Phase 1/2 Completed
45 enrolled 17 charts
PETAL
Phase 1/2 Completed
26 enrolled 9 charts
IT-01
Phase 1/2 Completed
111 enrolled 21 charts
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
Phase 1/2 Completed
323 enrolled
H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas
Phase 1/2 Completed
50 enrolled 12 charts
BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma
Phase 1/2 Completed
74 enrolled
KEYNOTE-B84
Phase 1/2 Completed
49 enrolled
Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery
Phase 1/2 Completed
50 enrolled 13 charts
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
Phase 1/2 Completed
26 enrolled 14 charts
TEIPP
Phase 1/2 Completed
26 enrolled
Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
Phase 1/2 Completed
26 enrolled 13 charts
Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma
Phase 1/2 Completed
25 enrolled 11 charts
MASTERKEY-318
Phase 1/2 Completed
127 enrolled 37 charts
Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma
Phase 1/2 Completed
27 enrolled 10 charts
Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer
Phase 1/2 Completed
264 enrolled 41 charts